AXGN

55.7501.06%
MA

Marc A. Began

Executive VP, General Counsel, Secretary & Chief Compliance Officer

Mr. Marc A. Began serves as Executive Vice President of AxoGen, Inc. since March 2023 and serves as its General Counsel since March 20, 2023 and serves as its Chief Compliance Officer and Secretary. He served as General Counsel and Secretary of Abiomed, Inc. since 2018 until December 22, 2022 and served as its Executive Vice President since April 1, 2022 until December 22, 2022 and served as its Vice President. Mr. Began was responsible for leading the legal, compliance and business development functions worldwide at Abiomed, Inc. He joined Abiomed in June 2018. He joined Abiomed from Boehringer Ingelheim where he was Vice President of intellectual property responsible for medical device, pharmaceutical and biologic intellectual property issues. Before joining Boehringer Ingelheim, Mr. Began held various positions of increasing responsibility at Novo Nordisk during many years. As assistant General Counsel, he oversaw complex litigation matters. Prior to that, as assistant Chief IP counsel, he managed global patent portfolios and enforcement strategy. He also supported strategic transactions and business development. Mr. Began has worked as a lawyer for more than 20 years, supporting various sectors of the life science industry, including pharmaceuticals, medical devices and biotechnology. Before joining Novo Nordisk, Mr. Began was an associate at the law firms of Sullivan & Cromwell LLP and White & Case LLP in New York, where he handled a broad range of legal matters, including litigation, intellectual property, corporate transactions, regulatory and compliance. Mr. Began earned a Juris Doctor degree from Albany Law School at Union University and holds a Bachelor of Science degree in Mechanical Engineering from Rensselaer Polytechnic Institute. He is also a licensed professional engineer and previously practiced engineering with the New York State Department of Environmental Conservation.

公司職務